Epsilon Healthcare Ltd Asset Resilience Ratio

Latest as of June 2023: 1.69%

Epsilon Healthcare Ltd asset resilience ratio. Epsilon Healthcare Ltd (EPN) has an Asset Resilience Ratio of 1.69% as of June 2023. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See EPN defensive interval ratio to measure how many days the company can operate on defensive assets alone.

Liquid Assets

AU$301.46K
≈ $213.30K USD Cash + Short-term Investments

Total Assets

AU$17.82 Million
≈ $12.61 Million USD All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio of Epsilon Healthcare Ltd (2016–2019)

Asset resilience ratio of Epsilon Healthcare Ltd from 2016 to 2019. This chart shows how Epsilon Healthcare Ltd's Asset Resilience Ratio has changed over time. Read Epsilon Healthcare Ltd total liabilities for a breakdown of total debt and financial obligations.

Liquid Assets Composition Over Time

This chart breaks down Epsilon Healthcare Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see EPN total assets.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents AU$301.46K 1.69%
Short-term Investments AU$0.00 0%
Total Liquid Assets AU$301.46K 1.69%

Asset Resilience Insights

  • Limited Liquidity: Epsilon Healthcare Ltd maintains only 1.69% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company primarily holds liquidity in cash and equivalents rather than short-term investments.

Epsilon Healthcare Ltd Industry Peers by Asset Resilience Ratio

Compare Epsilon Healthcare Ltd's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt
F:RIG2
Drug Manufacturers - Specialty & Generic 0.20%
Changchun High & New Technology Industries Group Inc
SHE:000661
Drug Manufacturers - Specialty & Generic 5.50%
Chengdu Kanghong Pharmaceuticals Group Co Ltd
SHE:002773
Drug Manufacturers - Specialty & Generic 29.37%
Zhejiang Hisun Pharmaceutical Co Ltd
SHG:600267
Drug Manufacturers - Specialty & Generic 0.01%
Shenzhen Chipscreen Biosciences Co
SHG:688321
Drug Manufacturers - Specialty & Generic 5.10%
Cronos Group Inc
TO:CRON
Drug Manufacturers - Specialty & Generic 69.94%
Jiangsu Kanion Pharmaceutical Co Ltd
SHG:600557
Drug Manufacturers - Specialty & Generic 0.29%
HPGC Renmintongtai Pharmaceutical Corp
SHG:600829
Drug Manufacturers - Specialty & Generic 0.00%

Epsilon Healthcare Ltd Asset Resilience Ratio by Year (2016–2019)

Epsilon Healthcare Ltd asset resilience ratio by year from 2016 to 2019. The table below shows the annual Asset Resilience Ratio data for Epsilon Healthcare Ltd.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2019-12-31 12.77% AU$3.55 Million
≈ $2.51 Million
AU$27.81 Million
≈ $19.68 Million
-6.57pp
2018-12-31 19.34% AU$6.33 Million
≈ $4.48 Million
AU$32.75 Million
≈ $23.17 Million
-30.95pp
2017-12-31 50.29% AU$11.04 Million
≈ $7.81 Million
AU$21.95 Million
≈ $15.53 Million
+42.57pp
2016-12-31 7.73% AU$885.37K
≈ $626.46K
AU$11.46 Million
≈ $8.11 Million
--
pp = percentage points

About Epsilon Healthcare Ltd

AU:EPN Australia Drug Manufacturers - Specialty & Generic
Market Cap
$5.51 Million
AU$7.78 Million AUD
Market Cap Rank
#28291 Global
#1450 in Australia
Share Price
AU$0.02
Change (1 day)
-13.04%
52-Week Range
AU$0.02 - AU$0.04
All Time High
AU$1.08
About

Epsilon Healthcare Limited, together with its subsidiaries, engages in the healthcare business in Australia. The company operates in three segments, Contract Development and Manufacturing Activities, Telehealth Medical Practice Services, and Pharmacy Services. It is involved in the healthcare and clinics operation; pharmaceutical contract development and manufacturing; development and manufacturi… Read more